CTNND2 and thymoma: Intriguingly, the mutation frequencies of CDC27 and CTNND2 trended to be higher in type B3 thymomas than in non‐B3 thymomas, implying that these cell proliferation and invasion‐associated gene17, 18 alterations may explain the more malignant features of the B3 subtype.